The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Tissue Diagnostic Market Projected To Become By 2030 Based On Its 2026 Valuation?
The tissue diagnostic market has experienced rapid expansion in recent years. The market is projected to expand from $6.38 billion in 2025 to $7.25 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 13.6%. Historically, this expansion has been driven by factors such as a rise in cancer diagnostic volumes, the enlargement of hospital pathology laboratories, increasing adoption of immunohistochemistry techniques, greater utilization of automated diagnostic instruments, and enhanced availability of advanced reagents.
The tissue diagnostic market is projected to experience substantial expansion over the coming years. This market is predicted to reach $11.97 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.4%. This anticipated growth during the forecast period is driven by factors such as a heightened demand for precision diagnostics, the escalating adoption of AI-assisted pathology tools, the broadening of personalized medicine initiatives, increasing investments in digital healthcare infrastructure, and a stronger emphasis on diagnostic accuracy and quicker turnaround times. Key trends emerging during the forecast period encompass the increasing integration of digital pathology platforms, a rise in the utilization of automated tissue staining systems, the growing incorporation of AI-based image analysis, the expansion of multiplex tissue assays, and an intensified focus on standardizing workflows.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6505&type=smp
What Drivers Are Shaping The Future Growth Of The Tissue Diagnostic Market?
The escalating prevalence of cancer is anticipated to fuel the expansion of the tissue diagnostic market throughout the forecast period. Cancer begins with genetic alterations that cause cells to multiply uncontrollably, destroying body tissue and forming a mass known as a tumor. A tumor can be either cancerous or benign. Various factors, such as genetic mutations, cancer-causing chemicals (carcinogens), smoking, obesity, radiation, and hormones, among others, can lead to cancer. As the number of cancer cases rises, there will be a substantial requirement for diagnostic methods like tissue diagnostics to aid in identifying the disease’s condition. For instance, in February 2024, the World Health Organization, a Switzerland-based United Nations agency, forecasted over 35 million new cancer cases in 2050, which is a 77% increase from the estimated 20 million cases in 2022. Consequently, the increasing incidence of cancer is a significant driver for the growth of the tissue diagnostic market.
What Segment Groups Are Identified Within The Tissue Diagnostic Market?
The tissue diagnostic market covered in this report is segmented –
1) By Product: Consumables, Antibodies, Kits, Reagents, Probes, Instruments, Slide Staining System, Scanner, Tissue Processing system
2) By Technology: Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology And Workflow Management, Special Staining
3) By Disease: Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC)
4) By End User: Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations
Subsegments:
1) By Consumables: Biopsy Needles, Slides And Cover Slips, Tissue Embedding Materials
2) By Antibodies: Primary Antibodies, Secondary Antibodies, Monoclonal Antibodies, Polyclonal Antibodies
3) By Kits: Diagnostic Kits, Assay Kits, Staining Kits
4) By Reagents: Fixatives, Staining Reagents, Antigen Retrieval Solutions
5) By Probes: Fluorescent Probes, Molecular Probes, Hybridization Probes
6) By Instruments: Microscopes, Tissue Microarray Instruments, Laser Capture Microdissection Instruments
7) By Slide Staining System: Automated Stainers, Manual Staining Systems
8) By Scanner: Digital Slide Scanners, Whole Slide Imaging Systems
9) By Tissue Processing System: Tissue Processors, Embedding Centers, Microtomes
What Trends Are Advancing Progress In The Tissue Diagnostic Market?
Leading firms in the tissue diagnostic market are concentrating on technological innovations, particularly the incorporation of artificial intelligence, to improve the accuracy and efficacy of diagnosing and treating prostate cancer. The application of AI in tissue diagnostics entails employing artificial intelligence algorithms for the analysis and interpretation of medical imagery and pathological information, thereby boosting the precision and speed of disease identification and categorization. As an example, in March 2023, Qritive, a healthcare company based in Singapore, introduced the Qai Prostate, an advanced artificial intelligence (AI)-driven instrument designed for pathologists to detect prostate cancer. This QAi prostate cancer diagnosis tool serves to identify regions of prostatic adenocarcinoma and differentiate between malignant and benign tumor sites within biopsy tissue samples. After these identifications and classifications, the system provides a comprehensive report detailing tumor size and the percentage for each slide or region of interest (ROI) pertinent to adenocarcinoma screening.
Which Companies Hold Significant Positions In The Tissue Diagnostic Market?
Major companies operating in the tissue diagnostic market are F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies Inc., Merck KGaA, BioGenex Laboratories, Sakura Finetek Co. Ltd., Philips Healthcare NV, Bio-Rad Laboratories, Ventana Medical Systems Inc., Hologic Inc., Becton Dickinson and Company, Sysmex Corporation, Cell Signaling Technology Inc., Enzo Life Sciences Inc., Leica Microsystems GmbH, Menarini Diagnostics S.r.l, PerkinElmer Inc., QIAGEN N.V., Siemens Healthineers AG, Zeiss Group AG
Read the full tissue diagnostic market report here:
https://www.thebusinessresearchcompany.com/report/tissue-diagnostic-global-market-report
Which Geographic Regions Are Influencing Demand In The Tissue Diagnostic Market?
North America was the largest region in the tissue diagnostic market in 2025. The regions covered in the tissue diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Tissue Diagnostic Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=6505&type=smp
Browse Through More Reports Similar to the Global Tissue Diagnostic Market 2026, By The Business Research Company
In Vitro Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report
Clinical Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report
Histology Equipment Market Report 2026
https://www.thebusinessresearchcompany.com/report/histology-equipment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model